Anthony Christopher Gordon


Ontology type: schema:Person     


Person Info

NAME

Anthony Christopher

SURNAME

Gordon

Publications in SciGraph latest 50 shown

  • 2021-11-20 Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials in BMC INFECTIOUS DISEASES
  • 2021-08-25 Levels of Autonomy and Safety Assurance for AI-Based Clinical Decision Systems in COMPUTER SAFETY, RELIABILITY, AND SECURITY. SAFECOMP 2021 WORKSHOPS
  • 2021-07-12 Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial in INTENSIVE CARE MEDICINE
  • 2021-05-14 Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials in NATURE COMMUNICATIONS
  • 2021-05-11 Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom in INTENSIVE CARE MEDICINE
  • 2021-04-15 Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials in NATURE COMMUNICATIONS
  • 2021-01-29 Current use of inotropes in circulatory shock in ANNALS OF INTENSIVE CARE
  • 2020-12-11 Genetic mechanisms of critical illness in COVID-19 in NATURE
  • 2020-08-24 Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials in TRIALS
  • 2020-07-31 ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial in TRIALS
  • 2020-02-03 Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial in INTENSIVE CARE MEDICINE
  • 2019-08-19 Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial in INTENSIVE CARE MEDICINE
  • 2019-05-07 Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience in BMC MEDICAL ETHICS
  • 2019-05-06 Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials in INTENSIVE CARE MEDICINE
  • 2019-05-03 Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials in CRITICAL CARE
  • 2019-01-30 Current use of vasopressors in septic shock in ANNALS OF INTENSIVE CARE
  • 2019 Lessons from the ICU: Choosing the Right Vasopressor in HEMODYNAMIC MONITORING
  • 2018-12-11 Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity in CRITICAL CARE
  • 2018-11-08 Innovation and safety in critical care: should we collaborate with the industry? Pro in INTENSIVE CARE MEDICINE
  • 2018-10-22 The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care in NATURE MEDICINE
  • 2018-10-03 Profiling inflammatory markers in patients with pneumonia on intensive care in SCIENTIFIC REPORTS
  • 2018-07-13 Terlipressin or norepinephrine, or both in septic shock? in INTENSIVE CARE MEDICINE
  • 2018-06-14 Sepsis: who will shoot first? Pharma or diagnostics? in INTENSIVE CARE MEDICINE
  • 2018-06-04 A global perspective on vasoactive agents in shock in INTENSIVE CARE MEDICINE
  • 2018-01-31 Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis in ANNALS OF INTENSIVE CARE
  • 2017-09-12 Derivation and validation of a prognostic model for postoperative risk stratification of critically ill patients with faecal peritonitis in ANNALS OF INTENSIVE CARE
  • 2017-05-12 The intensive care medicine research agenda on septic shock in INTENSIVE CARE MEDICINE
  • 2017-05-04 Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine in CRITICAL CARE
  • 2017-03-21 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3) in CRITICAL CARE
  • 2016-12-21 Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials in INTENSIVE CARE MEDICINE
  • 2016-10-01 Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy in INTENSIVE CARE MEDICINE
  • 2016-03-16 Metabonomics and intensive care in CRITICAL CARE
  • 2016 Metabonomics and Intensive Care in ANNUAL UPDATE IN INTENSIVE CARE AND EMERGENCY MEDICINE 2016
  • 2015-12-01 Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort in CRITICAL CARE
  • 2015-05-07 What’s new in vasopressin? in INTENSIVE CARE MEDICINE
  • 2015-03-16 Phenotypic factors associated with outcome in 977 intensive care patients with faecal peritonitis: analysis of trends in the GenOSept cohort in CRITICAL CARE
  • 2015-02-21 Evidence about inotropes: when is enough, enough? in INTENSIVE CARE MEDICINE
  • 2014-10-21 Thoracic Epidural analgesia versus Rectus Sheath Catheters for open midline incisions in major abdominal surgery within an enhanced recovery programme (TERSC): study protocol for a randomised controlled trial in TRIALS
  • 2014-09-26 0094. Monocyte tace activity profile during sepsis and systemic inflammatory response syndrome in INTENSIVE CARE MEDICINE EXPERIMENTAL
  • 2014-06-02 An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial in TRIALS
  • 2014-04-01 Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort in CRITICAL CARE
  • 2013-12-04 Patients with faecal peritonitis admitted to European intensive care units: an epidemiological survey of the GenOSept cohort in INTENSIVE CARE MEDICINE
  • 2013-06-20 Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine in CRITICAL CARE
  • 2012-10-01 An observational study to determine the effect of delayed admission to the intensive care unit on patient outcome in CRITICAL CARE
  • 2012-06-13 Design, conduct, and analysis of a multicenter, pharmacogenomic, biomarker study in matched patients with severe sepsis treated with or without drotrecogin Alfa (activated) in ANNALS OF INTENSIVE CARE
  • 2012 Vasopressor Therapy in ENCYCLOPEDIA OF INTENSIVE CARE MEDICINE
  • 2009-10-20 The effects of vasopressin on acute kidney injury in septic shock in INTENSIVE CARE MEDICINE
  • 2006-01-11 Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury in CRITICAL CARE
  • 2005-11-23 Goal directed therapy: how long can we wait? in CRITICAL CARE
  • 2004-11-04 TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study in GENES & IMMUNITY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.7445.2", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4868.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1002.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17091.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416553.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.451052.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.57981.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1008.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417895.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.426467.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416186.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412703.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.439749.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.83440.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416353.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13097.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413820.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.275559.9", 
            "type": "Organization"
          }
        ], 
        "familyName": "Gordon", 
        "givenName": "Anthony Christopher", 
        "id": "sg:person.01114060235.79", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-0419-547X"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114060235.79", 
          "https://orcid.org/0000-0002-0419-547X"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_788.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01114060235.79'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01114060235.79'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01114060235.79'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01114060235.79'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      11 PREDICATES      30 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01114060235.79 schema:affiliation Nc2bdb77ae6874530b9616c3833effdd7
    2 grid-institutes:grid.1002.3
    3 grid-institutes:grid.1008.9
    4 grid-institutes:grid.13097.3c
    5 grid-institutes:grid.17091.3e
    6 grid-institutes:grid.275559.9
    7 grid-institutes:grid.412703.3
    8 grid-institutes:grid.413820.c
    9 grid-institutes:grid.416186.c
    10 grid-institutes:grid.416353.6
    11 grid-institutes:grid.416553.0
    12 grid-institutes:grid.417895.6
    13 grid-institutes:grid.426467.5
    14 grid-institutes:grid.439749.4
    15 grid-institutes:grid.451052.7
    16 grid-institutes:grid.4868.2
    17 grid-institutes:grid.57981.32
    18 grid-institutes:grid.83440.3b
    19 schema:familyName Gordon
    20 schema:givenName Anthony Christopher
    21 schema:identifier N22f9c81ce32947bda38638879bda845b
    22 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114060235.79
    23 https://orcid.org/0000-0002-0419-547X
    24 schema:sdDatePublished 2022-12-01T07:13
    25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    26 schema:sdPublisher N5214f71b2d3a4786a78a7aaf32b2bb7a
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset persons
    29 rdf:type schema:Person
    30 N22f9c81ce32947bda38638879bda845b schema:name orcid_id
    31 schema:value 0000-0002-0419-547X
    32 rdf:type schema:PropertyValue
    33 N5214f71b2d3a4786a78a7aaf32b2bb7a schema:name Springer Nature - SN SciGraph project
    34 rdf:type schema:Organization
    35 Nc2bdb77ae6874530b9616c3833effdd7 schema:affiliation grid-institutes:grid.7445.2
    36 sgo:isCurrent true
    37 rdf:type schema:OrganizationRole
    38 grid-institutes:grid.1002.3 schema:Organization
    39 grid-institutes:grid.1008.9 schema:Organization
    40 grid-institutes:grid.13097.3c schema:Organization
    41 grid-institutes:grid.17091.3e schema:Organization
    42 grid-institutes:grid.275559.9 schema:Organization
    43 grid-institutes:grid.412703.3 schema:Organization
    44 grid-institutes:grid.413820.c schema:Organization
    45 grid-institutes:grid.416186.c schema:Organization
    46 grid-institutes:grid.416353.6 schema:Organization
    47 grid-institutes:grid.416553.0 schema:Organization
    48 grid-institutes:grid.417895.6 schema:Organization
    49 grid-institutes:grid.426467.5 schema:Organization
    50 grid-institutes:grid.439749.4 schema:Organization
    51 grid-institutes:grid.451052.7 schema:Organization
    52 grid-institutes:grid.4868.2 schema:Organization
    53 grid-institutes:grid.57981.32 schema:Organization
    54 grid-institutes:grid.7445.2 schema:Organization
    55 grid-institutes:grid.83440.3b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...